Clinical Trial Update: Reduced Intensity Haploidentical BMT for High Risk Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial investigating reduced-intensity haploidentical bone marrow transplantation for high-risk metastatic solid tumors; the study status is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Refractory and/or Relapsed Metastatic Solid Tumors | Phase 2 | Status: RECRUITING